Brief: Resverlogix Announces Recommendation From Data Safety Monitoring Board For Study Of Apabetalone

Resverlogix

26/02/2018 12:00

Feb 26 (Reuters) - Resverlogix Corp  RVX.TO : 
    * RESVERLOGIX ANNOUNCES SIXTH POSITIVE RECOMMENDATION FROM 
DATA 
SAFETY MONITORING BOARD FOR PHASE 3 STUDY OF APABETALONE 
    * FULL ENROLLMENT FOR BETONMACE PHASE 3 TRIAL CONTINUES TO 
BE 
ANTICIPATED IN FIRST HALF OF 2018 
 
Source text for Eikon:  ID:nGNX6F7cRb  
Further company coverage:  RVX.TO  
 
 ((Reuters.Briefs@thomsonreuters.com;))